BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 27716377)

  • 21. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
    Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
    Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early recognition of cardiac surgery-associated acute kidney injury: lack of added value of TIMP2 IGFBP7 over short-term changes in creatinine (an observational pilot study).
    Lakhal K; Bigot-Corbel E; Sacchetto E; Chabrun F; Senage T; Figueres L; Leroy M; Legrand A; Rozec B
    BMC Anesthesiol; 2021 Oct; 21(1):244. PubMed ID: 34641779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue Inhibitor Metalloproteinase-2·IGF-Binding Protein 7 for the Prediction of Acute Kidney Injury following Cardiac Surgery.
    Xie Y; Guo Q; Yang B; Xie P; Zhang J; Lu W; Ronco C; Jiang G
    Cardiorenal Med; 2024; 14(1):251-260. PubMed ID: 38588650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A promising marker in early diagnosis of septic acute kidney injury of critically ill patients: urine insulin like growth factor binding protein-7.
    Aydoğdu M; Boyacı N; Yüksel S; Gürsel G; Sivri AB
    Scand J Clin Lab Invest; 2016 Sep; 76(5):402-10. PubMed ID: 27240440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.
    Vijayan A; Faubel S; Askenazi DJ; Cerda J; Fissell WH; Heung M; Humphreys BD; Koyner JL; Liu KD; Mour G; Nolin TD; Bihorac A;
    Am J Kidney Dis; 2016 Jul; 68(1):19-28. PubMed ID: 26948834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary calprotectin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin for the prediction of adverse outcome in pediatric acute kidney injury.
    Westhoff JH; Seibert FS; Waldherr S; Bauer F; Tönshoff B; Fichtner A; Westhoff TH
    Eur J Pediatr; 2017 Jun; 176(6):745-755. PubMed ID: 28409285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Urinary Kidney Stress Biomarkers for Early Recognition of Subclinical Acute Kidney Injury in Critically Ill COVID-19 Patients.
    Casas-Aparicio G; Alvarado-de la Barrera C; Escamilla-Illescas D; León-Rodríguez I; Del Río-Estrada PM; Calderón-Dávila N; González-Navarro M; Olmedo-Ocampo R; Castillejos-López M; Figueroa-Hernández L; Peralta-Prado A; Luna-Villalobos Y; Piten-Isidro E; Fernández-Campos P; Ávila-Ríos S
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma neutrophil gelatinase-associated lipocalin as early biomarker for acute kidney injury in burn patients.
    Hong DY; Lee JH; Park SO; Baek KJ; Lee KR
    J Burn Care Res; 2013; 34(6):e326-32. PubMed ID: 23511281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)⋅IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI.
    Koyner JL; Shaw AD; Chawla LS; Hoste EA; Bihorac A; Kashani K; Haase M; Shi J; Kellum JA;
    J Am Soc Nephrol; 2015 Jul; 26(7):1747-54. PubMed ID: 25535301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU.
    Kari JA; Shalaby MA; Sofyani K; Sanad AS; Ossra AF; Halabi RS; Aljuhani MH; Toffaha WM; Moria FA; Sabry S; Ahmed HA; Alhasan KA; Sharief S; Safdar O
    World J Pediatr; 2018 Apr; 14(2):134-142. PubMed ID: 29464581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical adjudication in acute kidney injury studies: findings from the pivotal TIMP-2*IGFBP7 biomarker study.
    Liu KD; Vijayan A; Rosner MH; Shi J; Chawla LS; Kellum JA
    Nephrol Dial Transplant; 2016 Oct; 31(10):1641-6. PubMed ID: 27342580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary TIMP-2 and IGFBP7 for the prediction of acute kidney injury following cardiac surgery.
    Wang Y; Zou Z; Jin J; Teng J; Xu J; Shen B; Jiang W; Zhuang Y; Liu L; Luo Z; Wang C; Ding X
    BMC Nephrol; 2017 May; 18(1):177. PubMed ID: 28558754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil gelatinase-associated lipocalin is a better biomarker than cystatin C for the prediction of imminent acute kidney injury in critically ill patients.
    Yegenaga I; Kamis F; Baydemir C; Erdem E; Celebi K; Eren N; Baykara N
    Ann Clin Biochem; 2018 Mar; 55(2):190-197. PubMed ID: 28142264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combined approach for the early recognition of acute kidney injury after adult cardiac surgery.
    Zaouter C; Potvin J; Bats ML; Beauvieux MC; Remy A; Ouattara A
    Anaesth Crit Care Pain Med; 2018 Aug; 37(4):335-341. PubMed ID: 29777769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.
    Fuhrman DY; Kellum JA; Joyce EL; Miyashita Y; Mazariegos GV; Ganoza A; Squires JE
    Pediatr Transplant; 2020 Feb; 24(1):e13608. PubMed ID: 31652022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients.
    Makris K; Markou N; Evodia E; Dimopoulou E; Drakopoulos I; Ntetsika K; Rizos D; Baltopoulos G; Haliassos A
    Clin Chem Lab Med; 2009; 47(1):79-82. PubMed ID: 19055468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary [TIMP-2]·[IGFBP7]-guided randomized controlled intervention trial to prevent acute kidney injury in the emergency department.
    Schanz M; Wasser C; Allgaeuer S; Schricker S; Dippon J; Alscher MD; Kimmel M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1902-1909. PubMed ID: 29961888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetic eGFR and Novel AKI Biomarkers to Predict Renal Recovery.
    Dewitte A; Joannès-Boyau O; Sidobre C; Fleureau C; Bats ML; Derache P; Leuillet S; Ripoche J; Combe C; Ouattara A
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):1900-10. PubMed ID: 26342047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.